Compare SMWB & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMWB | BME |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Trusts Except Educational Religious and Charitable |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.8M | 545.3M |
| IPO Year | 2021 | N/A |
| Metric | SMWB | BME |
|---|---|---|
| Price | $3.90 | $42.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 649.8K | 34.0K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $275,429,000.00 | N/A |
| Revenue This Year | $16.87 | N/A |
| Revenue Next Year | $13.35 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | ★ 14.25 | N/A |
| 52 Week Low | $3.66 | $35.53 |
| 52 Week High | $12.01 | $43.20 |
| Indicator | SMWB | BME |
|---|---|---|
| Relative Strength Index (RSI) | 21.14 | 60.19 |
| Support Level | $3.66 | $41.81 |
| Resistance Level | $4.88 | $42.35 |
| Average True Range (ATR) | 0.40 | 0.49 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 11.35 | 94.35 |
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.